An inattentive & underreported cause of diabetic morbidity affecting the quality of life negatively is gastrointestinal (GI) symptoms along with a poor understanding of the pathophysiological linkage between glycaemic control.
The occurrence of diabetes-associated GI symptoms is dependent on body mass index, gender, psychological comorbidities, helicobacter pylori infection & age. It is higher in women with greater psychological distress, anxiety & depression.
Chronic diabetic gastroparesis leads to complications like ulcer peptic disease, partial gastric or intestinal obstruction, gastric cancer, and pancreatic biliary disorders
Frequent diabetic GI symptoms
Mostly influenced by the nerve damage intensity, glycaemic control, diet & therapy compliance.
Pathophysiology
Key causes are of endocrine, neurological, and metabolic origin. It is initiated by delayed gastric emptying associated with multiple motor & sensory upper gut function abnormalities.
Blood glucose level & gut functioning
Insulin delivery which is linked with carbohydrate absorption makes crucial changes in the gastric motility of diabetics. Postprandial antral contraction & gastric motility reduce during hyperglycemia and increase during hypoglycemia. Enhanced blood glucose levels cause disturbances in proximal stomach perception, reversible vagal efferent dysfunction & provide an always stomach fullness feeling.
Remedies
Conclusion
The usage of validated measures to quantify GI symptoms in diabetics & unwrapping the appropriate pathology in the right way are crucial for both the diagnosis & management of diabetic gastroparesis.
To handle difficult diabetic gastroparesis cases, an experienced healthcare team with a flexible perspective & supreme alertness toward the presence of autonomic issues & complications in patients is mandatory. Cumulatively efforts will improve gastroparesis symptoms throughout therapy.
References
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Prostate cancer Q&A: Improving detection and reducing overtreatment
2.
FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting
3.
A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.
4.
Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL
5.
New imaging technique identifies glioblastoma patients who would benefit from immunotherapy
1.
Understanding Villous Adenoma: Causes, Symptoms, and Treatments
2.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
3.
Generative AI for Adaptive Oncology Trial Design
4.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
5.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
From Guidelines to Practice: Hematology
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation